Anbio Biotechnology’s IPO opens up 5%

Published 19/02/2025, 18:08
© Reuters.

Investing.com -- Anbio Biotechnology, a global diagnostic company, announced the pricing of its initial public offering (IPO) at $5.00 per Class A Ordinary Share. However, the shares opened at a higher price of $5.26 per share on Wednesday, a 5% increase. Anbio is releasing 1,600,000 Class A ordinary shares in this offering. Anbio is currently trading on the Nasdaq stock exchange under the ticker "NNNN".

Anbio anticipates receiving total gross proceeds of $8 million from this offering, before subtracting underwriting discounts and other associated expenses. AC Sunshine Securities LLC is serving as the underwriter for this offering.

Anbio Biotechnology is a company committed to advancing medical technology and providing in vitro diagnostics (IVD) products. The company offers a diverse portfolio of mature diagnostic assays and five key platforms for biomarker detection. These platforms include Fluorescent Immunochromatographic Solution (FIA), Chemiluminescent Immunoassay Solution (ChLIA), Polymerase Chain Reaction Solution (PCR), Lateral Flow Assay Solution (LFIA), and Loop-Mediated Isothermal Amplification Solution (LAMP).

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.